contact profile privacysearch log in


Results from Late Stage Bladder Cancer Clinical Trial Conducted by SUO-CTC Are Published in the Lancet Oncology
December 2, 2020

A breakthrough therapy discovered during Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) Phase 2 and 3 trials was published by The Lancet Oncology.

Mark Your Calendars!
July 24, 2020

The SUO 21st Annual Meeting will be held virtually on December 3 – 5. The in-person meeting at the Sheraton Dallas has been cancelled.

Discovery Brings Bladder Cancer Patients Hope
May 5, 2020

Medical Breakthrough Tested in Phase 2 and 3 Trials from Society of Urologic Oncology Clinical Trials Consortium

SUO AUA Events Cancelled
March 17, 2020

Due to the rapidly escalating health concerns and developments related to the global coronavirus (COVID-19), the AUA 2020 Annual Meeting in Washington, DC has been cancelled. 

SUO Moves Forward with Focused Practice Designation in Urologic Oncology
October 3, 2019

Thank you all for participating in the online vetting process for the SUO application for a Focused Practice Designation (FPD) in Urologic Oncology. The comments section provided much useful feedback regarding both support and areas of concern.

Framing Pragmatic Strategies to Reduce Mortality from Urothelial Cancer
April 2, 2019

In 2018, the estimated number of new cases of urothelial bladder cancer (UC) in the United States was 81,000, with 17,240 estimated deaths. Comparable numbers from 2004 were approximately 64,000 and 12,000, respectively... Why has mortality from UC... remained unchanged for over 30 years?

BCG Shortage Addressed by Urologic Community
February 20, 2019

This week, the Society of Urologic Oncology joined the American Urological Association, Bladder Cancer Advocacy Network, American Association of Clinical Urologists, LUGPA and Urology Care Foundation to express extreme concern about the shortage of TICE BCG and its effects on the care of patients with bladder cancer.

AJCC Cancer Staging Resources
February 4, 2019

The American Joint Committee on Cancer (AJCC) has made available two important tools related to cancer staging on their website.

SUO Statement on Genetic Counseling and Genetic Testing In the Management of Prostate Cancer
December 11, 2018

The role of genetic testing in prostate cancer is rapidly evolving. A substantial proportion of men with prostate cancer carry inherited genetic mutations in cancer risk genes, with estimates as high as 15% in men with metastatic castration resistant disease.

Focused Practice Designation for Urologic Oncology
August 8, 2018

The American Board of Urology is beginning a new designation, called Focused Practice Designation (FPD). The purpose of the FPD is to recognize an area of sub-specialization within a specialty without the onerous need for the formal process of CAQ.

Recap of the SUO 18th Annual Meeting
December 20, 2017

The Society of Urologic Oncology recently wrapped up another successful program at the 18th Annual Meeting. The Society saw its highest attendance yet with over 750 medical professionals present to learn about emerging medical techniques and engage in educational discussions. Meeting attendance is not the only thing on the rise, either, with membership in the Society nearing 1,000 members.

Novel Gene Therapy Shows Three-Fold Improvement in Recurrence-Free Survival in High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails
August 24, 2017

Durable responses in 35 percent of patients reported in Phase II data published in the Journal of Clinical Oncology

SUO Journal Ranks 13th Out Of 76 Publications
June 20, 2017

I am delighted on behalf of the editors and publisher of "Urologic Oncology: Seminars and Original Investigations" to share the exciting news of a dramatic increase in the journal's impact factor.

SUO Members Honored at the SUO Meeting at the AUA
June 15, 2017

Three SUO members were honored at the SUO 2017 Annual Meeting at the AUA Saturday, May 13. 

SUO Responds to USPSTF Draft Recommendations on Screening for Prostate Cancer
April 18, 2017

The Society of Urologic Oncology (SUO) endorses the American Urological Association’s comments about the United States Preventative Services Task Force’s (USPSTF’s) updated statement on PSA screening for prostate cancer.

Congratulations to Dr. John L. Gore!
May 16, 2016

Congratulations to Dr. John L. Gore, University of Washington, on his impressive second-place performance at the Early Career Investigators Showcase at the recent AUA meeting in San Diego, for his work entitled, "Patient-Centered Design and Implementation of Survivorship Tools for Men with Prostate Cancer".

Introducing the SUO Career Center!
March 10, 2016

Introducing the SUO Career Center